Cargando…
Gene Expression Profile as a Predictor of Seizure Liability
Analysis platforms to predict drug-induced seizure liability at an early phase of drug development would improve safety and reduce attrition and the high cost of drug development. We hypothesized that a drug-induced in vitro transcriptomics signature predicts its ictogenicity. We exposed rat cortica...
Autores principales: | Lipponen, Anssi, Kajevu, Natallie, Natunen, Teemu, Ciszek, Robert, Puhakka, Noora, Hiltunen, Mikko, Pitkänen, Asla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963992/ https://www.ncbi.nlm.nih.gov/pubmed/36835526 http://dx.doi.org/10.3390/ijms24044116 |
Ejemplares similares
-
Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology
por: Kajevu, Natallie, et al.
Publicado: (2023) -
Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury
por: Kyyriäinen, Jenni, et al.
Publicado: (2021) -
Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets
por: Lipponen, Anssi, et al.
Publicado: (2016) -
Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury
por: Das Gupta, Shalini, et al.
Publicado: (2019) -
In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury—Lessons Learned
por: Lipponen, Anssi, et al.
Publicado: (2019)